Thermo Fisher Scientific Inc (TMO)

NYSE
Currency in USD
429.00
+1.47(+0.34%)
Closed·
After Hours
428.99-0.01(0.00%)
·
TMO Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
422.99429.29
52 wk Range
409.85627.88
Key Statistics
Edit
Prev. Close
427.53
Open
427.65
Day's Range
422.99-429.29
52 wk Range
409.85-627.88
Volume
2.76M
Average Volume (3m)
2.24M
1-Year Change
-25.91%
Book Value / Share
130.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TMO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
575.00
Upside
+34.03%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 7 consecutive years
Show more

Thermo Fisher Scientific Inc Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc SWOT Analysis


Market Resilience
Thermo Fisher Scientific demonstrates strong performance in Life Science Tools & Diagnostics, outpacing peers and exceeding expectations amid market shifts
Financial Outlook
Explore Thermo Fisher's projected 3-4% organic growth and 90 basis points EBIT margin expansion for FY2025, with EPS estimates ranging from $23.10 to $23.50
Global Dynamics
Delve into Thermo Fisher's navigation of Chinese market uncertainties and potential benefits from regional stimulus efforts, balancing risks and opportunities
Strategic Positioning
Uncover Thermo Fisher's competitive edge in bioproduction and its impact on long-term growth prospects, showcasing the company's adaptability in a dynamic industry
Read full SWOT analysis

Thermo Fisher Scientific Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $5.15 beat $5.11 forecast; revenue of $10.36B slightly above expectations; stock rose 4.25% post-announcement
  • Organic revenue growth at 1%; adjusted operating income $2.27B with 21.9% margin; flat growth in North America, low single-digit in Europe/Asia Pacific
  • Updated 2025 guidance: revenue $43.3B-$44.2B, adjusted EPS $21.76-$22.84; anticipates 2% organic revenue growth
  • Announced acquisition of Solventum's purification and filtration business for $4.1B; $2B commitment to U.S. manufacturing and R&D over 4 years
  • CEO emphasized company's agility in current market; analysts concerned about U.S.-China tariffs impact and long-term market growth
Last Updated: 23/04/2025, 14:46
Read Full Transcript

Compare TMO to Peers and Sector

Metrics to compare
TMO
Peers
Sector
Relationship
P/E Ratio
24.8x−3.5x−0.5x
PEG Ratio
2.630.040.00
Price/Book
3.3x1.5x2.6x
Price / LTM Sales
3.8x1.8x2.9x
Upside (Analyst Target)
33.9%63.9%56.4%
Fair Value Upside
Unlock22.3%9.3%Unlock

Analyst Ratings

25 Buy
6 Hold
0 Sell
Ratings:
31 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 575.00
(+34.03% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 17.10%
Dividend Yield
0.40%
Industry Median 0.71%
Annualised payout
1.72
Paid quarterly
5-Years Growth
+15.16%
Growth Streak

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
5.15 / 5.11
Revenue / Forecast
10.36B / 10.23B
EPS Revisions
Last 90 days

People Also Watch

50.16
BMY
+1.91%
195.10
ABBV
+0.82%
373.81
SYK
+0.78%
85.12
MRK
+0.48%
106.54
GILD
+2.24%

FAQ

What Stock Exchange Does Thermo Fisher Scientific Trade On?

Thermo Fisher Scientific is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Thermo Fisher Scientific?

The stock symbol for Thermo Fisher Scientific is "TMO."

What Is the Thermo Fisher Scientific Market Cap?

As of today, Thermo Fisher Scientific market cap is 161.84B.

What is Thermo Fisher Scientific Earnings Per Share?

The Thermo Fisher Scientific EPS is 17.10.

What Is the Next Thermo Fisher Scientific Earnings Date?

Thermo Fisher Scientific will release its next earnings report on 22 Jul 2025.

From a Technical Analysis Perspective, Is TMO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.